Evidence map›Paper›PMID 38994864›Full record

ArticleTurkish journal of pharmaceutical sciences2024

Evaluation of Herbal Products and Dietary Supplements Use in Patients with Respiratory Diseases Applied to Tertiary Health Institution.

Tuğba Subaş, Ufuk Özgen, Yılmaz Bülbül, Tevfik Özlü, Gülin Renda, Abdul Kadir Albayraktar

Abstract read
In one paragraph

Article in Turkish journal of pharmaceutical sciences, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Tuğba SubaşKaradeniz Technical University Faculty of Pharmacy, Department of Pharmacognosy, Trabzon, Türkiye.ORCID 0000-0002-0956-6567
Ufuk ÖzgenKaradeniz Technical University Faculty of Pharmacy, Department of Pharmacognosy, Trabzon, Türkiye.ORCID 0000-0001-9839-6717
Yılmaz BülbülKaradeniz Technical University Faculty of Medicine, Department of Chest Diseases, Trabzon, Türkiye.ORCID 0000-0002-8488-3650
Tevfik ÖzlüKaradeniz Technical University Faculty of Medicine, Department of Chest Diseases, Trabzon, Türkiye.ORCID 0000-0003-4881-3097
Gülin RendaKaradeniz Technical University Faculty of Pharmacy, Department of Pharmacognosy, Trabzon, Türkiye.ORCID 0000-0001-6323-0338
Abdul Kadir AlbayraktarKaradeniz Technical University Faculty of Medicine, Department of Public Health, Trabzon, Türkiye.ORCID 0000-0002-3708-4493

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objectives: In recent years, especially with the Coronavirus Disease of 2019 (COVID-19) pandemic, the use of herbal products for various health problems has been increasing worldwide. This study aimed to determine the frequency of herbal product/dietary supplement use, the most used products, and the factors affecting the use of these products in patients who applied to the Chest Diseases Clinic. Materials and Methods: This descriptive survey study was conducted at Chest Diseases Clinic using a face-to-face interview technique. Adult individuals with subacute respiratory complaints for > 3 weeks or a diagnosis of chronic chest disease were included in the study. The questionnaire form included questions about personal characteristics, data related to disease and treatment, use of herbal products/dietary supplements, and attitudes toward these products. A total of 444 participants with all the data included in the study. Descriptive statistics, chi-square, and binary logistic regression tests were used. Results: It was determined that 49.3% of the participants used herbal products/dietary supplements, and the most frequently used products were honey, linden, ginger, lemon, and carob. According to the results of the binary logistic regression test, it was determined that patients over 60 years old [odds ratio (OR)= 2.0, 95% confidence interval (Cl): 1.1-3.8, Conclusion: Considering the high probability of using these products in patients with respiratory tract disease, it is essential for public health that health professionals question the use of these products and provide counseling on this issue.

Indexed as

dietary supplementsherb-drug interactionsMedicinal herbpharmacistrespiratory diseases

Identifiers

PMID38994864
PMCPMC11590546

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.